Danaher Corporation vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while YieldMax TSLA Option Income Strategy ETF trades at $22.45 (market cap $697.51M). The key difference: Danaher Corporation is far larger — about 219.2× YieldMax TSLA Option Income Strategy ETF's market cap, and Danaher Corporation pays a 0.74% dividend while YieldMax TSLA Option Income Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and YieldMax TSLA Option Income Strategy ETF for 43 Days on average.
| DHR | TSLY | |
|---|---|---|
Market Cap | $152.87B | $697.51M |
Volume | 5,228,698 | 338,271 |
Sector | Health | Income / Options Overlay |
52-Week High | $242.05 | $43.35 |
52-Week Low | $161.91 | $20.49 |
Typical Hold Time | 69 Days | 43 Days |
Enterprise Value | $175.08B | — |
Dividend Yield | 0.74% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
TSLY trades at $22.27, down 1.46% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF generates high income through weekly dividends, averaging around $0.21-$0.26 per share recently. Recent news highlights consistent distribution announcements but also notes underperformance versus Tesla's equity rally due to its option income strategy structure.
The outlook is mixed: high yield appeals to income seekers, but the strategy caps upside during Tesla rallies. Key risks include dependence on Tesla's volatility and potential NAV erosion. Investors should weigh income generation against limited capital appreciation potential in a bullish Tesla market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →